HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by CARDOSO, I. Articles by SARAIVA, M. J. Search for Related Content PubMed PubMed Citation Articles by CARDOSO, I. Articles by SARAIVA, M. J.

4'-iodo-4'-Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters

ISABEL CARDOSO^*,, GIAMPAOLO MERLINI and MARIA JOO SARAIVA^*,,1

^* Amyloid Unit, Institute for Molecular and Cell Biology and
ICBAS, University of Porto, Portugal; and
Biotechnology Research Laboratories, University Hospital IRCCS Policlinico San Matteo and Department of Biochemistry, University of Pavia, Italy

¹Correspondence: Amyloid Unit, IBMC, Rua do Campo Alegre, 823, P-4150-180 Porto, Portugal. E-mail: mjsaraiv{at}ibmc.up.pt

Transthyretin Leu55Pro is one of the most aggressive mutations in familial amyloidotic polyneuropathy, an autosomal dominant disorder characterized by extracellular deposition of fibrillar amyloid protein. This variant has the ability to form fibrils in vitro under physiological conditions (PBS, pH 7.4). We studied by transmission electron microscopy the effect of the drug 4'-iodo-4'-deoxydoxorubicin (I-DOX) on the in vitro assembly of TTR Leu55Pro fibrils by following fibril growth over a 15 day period. Our results showed that I-DOX at a concentration of 10^-5 M/100 µg fibrils does not inhibit fibril formation in up to 10 days since fibrils identical to the ones present in the untreated sample were observed. However, after 15 days of treatment, only round particles, resembling soluble native TTR, were observed. We also tested the ability of tetracyclines and nitrophenols to interfere with amyloid fibril formation for 17 days; the group of compounds tested showed fibril disruption activity to different extents: doxycycline and 2,4-dinitrophenol resulted in complete disaggregation of fibrils. The species generated upon I-DOX and tetracyclines treatments were nontoxic, as revealed by the lack of significant caspase-3 activation on a Schwannoma cell line, making them potential therapeutic drugs in TTR-related and other amyloidosis.—Cardoso, I., Merlini, G., Saraiva, M. J. 4'-iodo-4'-Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters.

Key Words: familial amyloidotic polyneuropathy • transthyretin • I-DOX • tetracyclines • amyloid disruption

This article has been cited by other articles:

				H. Zhang, J. Sawashita, X. Fu, T. Korenaga, J. Yan, M. Mori, and K. Higuchi Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods FASEB J, May 1, 2006; 20(7): 1012 - 1014. [Abstract] [Full Text] [PDF]

				I. Cardoso and M. J. Saraiva Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model FASEB J, February 1, 2006; 20(2): 234 - 239. [Abstract] [Full Text] [PDF]

				J. N. Buxbaum Treatment and prevention of the amyloidoses: Can the lessons learned be applied to sporadic inclusion-body myositis? Neurology, January 24, 2006; 66(1_suppl_1): S110 - S113. [Abstract] [Full Text] [PDF]

				M. Pickhardt, Z. Gazova, M. von Bergen, I. Khlistunova, Y. Wang, A. Hascher, E.-M. Mandelkow, J. Biernat, and E. Mandelkow Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells J. Biol. Chem., February 4, 2005; 280(5): 3628 - 3635. [Abstract] [Full Text] [PDF]

				F. G. DE FELICE, M. N. N. VIEIRA, L. M. SARAIVA, J. D. FIGUEROA-VILLAR, J. GARCIA-ABREU, R. LIU, L. CHANG, W. L. KLEIN, and S. T. FERREIRA Targeting the neurotoxic species in Alzheimer's disease: inhibitors of A{beta} oligomerization FASEB J, September 1, 2004; 18(12): 1366 - 1372. [Abstract] [Full Text] [PDF]